Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse
暂无分享,去创建一个
K Fenwick | A. Ashworth | O. Dovey | S. Gregory | J. Reis-Filho | A. Grigoriadis | R. Williams | R. Natrajan | K. Fenwick | A. Mackay | K. Pritchard-Jones | P. Grundy | B. Weber | S. Hing | J S Reis-Filho | M. Iravani | J. Reis-Filho | H. Valgeirsson | C. Jones | B L Weber | P E Grundy | A Mackay | K Pritchard-Jones | A Ashworth | M Iravani | C Jones | R Natrajan | R D Williams | S N Hing | H Valgeirsson | A Grigoriadis | C F Langford | O Dovey | S G Gregory | C. Langford | R. Williams | Chris Jones | PE Grundy | SN Hing | CF Langford | SG Gregory | SN Hing | PE Grundy | Barbara L. Weber | Haukur Valgeirsson | Chris Jones
[1] R. Bentley,et al. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors. , 2005, Journal of pediatric surgery.
[2] Emmanuel Barillot,et al. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions , 2004, Bioinform..
[3] J. Mulvihill,et al. Chromosome 2q terminal deletion: Report of 6 new patients and review of phenotype‐breakpoint correlations in 66 individuals , 2004, American journal of medical genetics. Part A.
[4] Toshio Kuroki,et al. Role of Smad4 (DPC4) inactivation in human cancer. , 2003, Biochemical and biophysical research communications.
[5] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.
[6] M. Coppes,et al. Management of Wilms' tumour: current practice and future goals. , 2004, The Lancet. Oncology.
[7] Kenny Q. Ye,et al. Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.
[8] A. Cnaan,et al. Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Russ B. Altman,et al. Missing value estimation methods for DNA microarrays , 2001, Bioinform..
[10] S. Blaschke,et al. Expression of cadherin‐8 in renal cell carcinoma and fetal kidney , 2002, International journal of cancer.
[11] D. Gisselsson,et al. Wilms tumors develop through two distinct karyotypic pathways. , 2004, Cancer genetics and cytogenetics.
[12] C. Croce,et al. miRNAs, Cancer, and Stem Cell Division , 2005, Cell.
[13] Simon Rogers,et al. Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines , 2004, Genes, chromosomes & cancer.
[14] P. Scambler,et al. Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour. , 1998, British Journal of Cancer.
[15] C. Langford,et al. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci. , 2005, Cancer research.
[16] Y. Yatabe,et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. , 2005, Cancer research.
[17] Gerald C. Chu,et al. TGFβ superfamily signals are required for morphogenesis of the kidney mesenchyme progenitor population , 2004, Development.
[18] Ximing J. Yang,et al. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. , 2002, Cancer research.
[19] Jason E. Stewart,et al. Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.
[20] E. Eichler,et al. Fine-scale structural variation of the human genome , 2005, Nature Genetics.
[21] A. Kelsey,et al. Cytogenetic abnormalities and clinical outcome in Wilms tumor: a study by the U.K. cancer cytogenetics group and the U.K. Children's Cancer Study Group. , 2002, Medical and pediatric oncology.
[22] N. Breslow,et al. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor. , 1999, Cancer research.
[23] D. Govender,et al. Microsatellite analysis of the DCC gene in nephroblastomas: pathologic correlations and prognostic implications , 2004, Modern Pathology.
[24] M. Gessler,et al. Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. , 2001, The American journal of pathology.
[25] K. Gow,et al. Cytogenetic and histologic findings in Wilms' tumor. , 2002, Journal of pediatric surgery.
[26] N Breslow,et al. Epidemiology of Wilms tumor. , 1993, Medical and pediatric oncology.
[27] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[28] J. Barber,et al. Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. , 2003, American journal of human genetics.
[29] S. S. Young,et al. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .
[30] A. Ashworth,et al. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity , 2005, The Journal of pathology.
[31] L. Feuk,et al. Detection of large-scale variation in the human genome , 2004, Nature Genetics.
[32] Jane Fridlyand,et al. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. , 2005, Human molecular genetics.
[33] S. Dudoit,et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.
[34] Carlos Caldas,et al. A Recurrent Chromosome Breakpoint in Breast Cancer at the NRG1/Neuregulin 1/Heregulin Gene , 2004, Cancer Research.
[35] N. Breslow,et al. Loss of Heterozygosity for Chromosomes 16q and Ip in Wilms' Tumors Predicts an Adverse Outcome' , 2022 .
[36] W. Kuo,et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.
[37] D. Green,et al. The treatment of stages I-IV favorable histology Wilms' tumor. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] N. Breslow,et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] B. Williams,et al. Transcript profiling of Wilms tumors reveals connections to kidney morphogenesis and expression patterns associated with anaplasia , 2005, Oncogene.
[40] G. Mills,et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers , 2004, Nature Medicine.
[41] P. Goodfellow,et al. 16q loss of heterozygosity and microsatellite instability in Wilms' tumor. , 2000, Journal of pediatric surgery.
[42] A. Reeve,et al. A gene expression signature for relapse of primary wilms tumors. , 2005, Cancer research.
[43] Yong-jie Lu,et al. Chromosome 1q expression profiling and relapse in Wilms' tumour , 2002, The Lancet.
[44] Shaying Zhao,et al. 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis. , 2003, Genome research.
[45] D. Welch,et al. KISS1 metastasis suppression and emergent pathways , 2004, Clinical & Experimental Metastasis.
[46] D. Schofield,et al. Identification of the neurotrophin receptors p75 and trk in a series of Wilms' tumors. , 1994, The American journal of pathology.